Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute-on-chronic liver failure

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 8, 2013, Pages 1361-1367

  Garg, Hitendra ^a,b   Kumar, Ashish ^a   Garg, Vishal ^b   Kumar, Manoj ^a   Kumar, Ramesh ^a   Sharma, Barjesh Chander ^b   Sarin, Shiv Kumar ^a  

^a INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

^b G B PANT HOSPITAL   (India)

Author keywords

ACLF; Acute on chronic liver failure; Hepatic venous pressure gradients; Pulmonary hemodynamics; Systemic hemodynamics

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; BILIRUBIN; CREATININE; LACTULOSE; PROTON PUMP INHIBITOR; SODIUM; TERLIPRESSIN;

ACUTE ON CHRONIC LIVER FAILURE; ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; AORTA PRESSURE; ARTICLE; ASCITES; BACTERIAL PERITONITIS; BILIRUBIN BLOOD LEVEL; CARDIOPULMONARY HEMODYNAMICS; CHILD TURCOTTE PUGH SCORE; CREATININE BLOOD LEVEL; HEART INDEX; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; MORTALITY; PORTAL VEIN BLOOD PRESSURE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SODIUM BLOOD LEVEL; SURVIVAL RATE; SYSTEMIC VASCULAR RESISTANCE; UPPER GASTROINTESTINAL BLEEDING;

EID: 84880666701     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12191     Document Type: Article

References (21)

1. Ripoll C, Groszmann R, Garcia-Tao G etal. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007; 133: 481-488.
2. Lebrec D, De Fleury P, Rueff B, Nahum H, Benhamou JP. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 1980; 79: 1139-1144.
3. Sarin SK, Kumar A, Almeida JA etal. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol. Int. 2009; 3: 269-282.
4. Wasmuth HE, Kunz D, Yagmur E etal. Patients with acute on chronic liver failure display "sepsis-like" immune paralysis. J. Hepatol. 2005; 42: 195-201.
5. Mookerjee RP. Acute-on-chronic liver failure: liver and portal haemodynamics. Curr. Opin. Crit. Care 2011; 17: 170-176.
6. Lee KC, Yang YY, Wang YW etal. Increased plasma malondialdehyde in patients with viral cirrhosis and its relationships to plasma nitric oxide, endotoxin, and portal pressure. Dig. Dis. Sci. 2010; 55: 2077-2085.
7. Garg H, Kumar A, Garg V, Sharma P, Sharma BC, Sarin SK. Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure. Dig. Liver Dis. 2011; 44: 166-171. [Epub ahead of print].
8. Garg H, Sarin SK, Kumar M, Garg V, Sharma BC, Kumar A. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology 2011; 53: 774-780.
9. Kumar A, Das K, Jain A etal. Hepatic venous pressure gradient, systemic and pulmonary hemodynamics in patients with acute-on-chronic liver failure. Dig. Dis. Sci. 2009; 54: 869-878.
10. Manolakopoulos S, Triantos C, Theodoropoulos J etal. Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronichepatitis B and significant portal hypertension. J. Hepatol. 2009; 51: 468-474.
11. Vorobioff J, Groszmann RJ, Picabea E etal. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. Gastroenterology 1996; 111: 701-709.
12. Groszmann RJ, Glickman M, Blei AT, Storer E, Conn HO. Wedged and free hepatic venous pressure measured with a balloon catheter. Gastroenterology 1979; 76: 253-258.
13. Sen S, Mohensi S, Sjodin L etal. Baseline SOFA scores and its lack of early improvement accurately predicts mortality in patients with acute-on-chronic liver failure. Hepatology 2004; 40 (Suppl. 1): 489A.
14. Mookerjee RP, Wiesenthal A, Icking A etal. Increased gene and protein expression of the novel eNOS regulatory protein NOSTRIN and a variant in alcoholic hepatitis. Gastroenterology 2007; 132: 2533-2541.
15. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med. 2000; 343: 1467-1476.
16. Stauber RE, Stadlbauer V, Struber G, Kaufmann P. Evaluation of four prognostic scores in patients with acute-on-chronic liver failure. J. Hepatol. 2006; 44 (Suppl. 2): S69-70.
17. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N. Engl. J. Med. 1988; 13: 983-989.
18. Navasa M, Garcia-Pagan JC, Bosch J etal. Portal hypertension in acute liver failure. Gut 1992; 33: 965-968.
19. Javle P, Yates J, Kynaston HG, Parsons KF, Jenkins SA. Hepatosplanchnic haemodynamics and renal blood flow and function in rats with liver failure. Gut 1998; 43: 272-279.
20. Sen S, Mookerjee RP, Cheshire LM, Davies NA, Williams R, Jalan R. Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis. J. Hepatol. 2005; 43: 142-148.
21. Catalina MV, Barrio J, Anaya F etal. Hepatic and systemic haemodynamic changes after MARS in patients with acute-on-chronic liver failure. Liver Int. 2003; 23 (Suppl. 3): 39-43.